Latest Alphavirus Stories
An experimental vaccine developed using non-infectious virus-like particles (VLP) has protected macaques and mice against chikungunya virus, a mosquito-borne pathogen that has infected millions of people in Africa and Asia and causes debilitating pain, researchers at the National Institutes of Health have found.
RESEARCH TRIANGLE PARK, N.C., Feb. 16 /PRNewswire/ -- AlphaVax announced today that it has hired Lynn Baird, PhD, as Vice President of Regulatory, Quality and Clinical Operations.
US-based clinical-stage company AlphaVax has initiated a Chlamydia vaccine program based on its alphavirus vector platform technology.
RESEARCH TRIANGLE PARK, N.C., July 21 /PRNewswire/ -- AlphaVax announced today the initiation of a Chlamydia vaccine program based on its alphavirus vector platform technology.
The Semliki Forest virus was isolated from mosquitoes in the Semliki Forest in 1942. It can cause disease in both animals and man. It's an Alphavirus found in central, eastern, and southern Africa. It is a positive-stranded RNA virus. It is spread mainly by mosquito bites and infects mammals through inhalation or gastrointestinal exposure. The virus can cause lethal encephalitis in rodents; however, only one fatal infection has been reported in humans. This patient was immunodeficient and...
Eastern equine encephalitis virus (EEE), also called sleeping sickness or Triple E, is a zoonotic alphavirus and arbovirus that exists in the Americas and the Caribbean. It was first seen in Massachusetts in 1831 when 75 horses died of encephalitic illness. It is often associated with coastal plains. EEE was first isolated from the brain of an infected horse in 1933. In 1938 the first human case was confirmed when thirty children died of encephalitis in northeaster United States...
- The act of sweetening by admixture of some saccharine substance.